ALK-Abelló A/S (CPH: ALK.B)
178.00
0.00 (0.00%)
Aug 29, 2024, 4:59 PM CET
ALK-Abelló Revenue
ALK-Abelló had revenue of 1.37B DKK in the quarter ending June 30, 2024, with 21.06% growth. This brings the company's revenue in the last twelve months to 5.18B, up 10.68% year-over-year. In the year 2023, ALK-Abelló had annual revenue of 4.82B with 6.94% growth.
Revenue (ttm)
5.18B
Revenue Growth
+10.68%
P/S Ratio
7.43
Revenue / Employee
1.85M
Employees
2,824
Market Cap
39.59B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.82B | 313.00M | 6.94% |
Dec 31, 2022 | 4.51B | 595.00M | 15.19% |
Dec 31, 2021 | 3.92B | 425.00M | 12.17% |
Dec 31, 2020 | 3.49B | 217.00M | 6.63% |
Dec 31, 2019 | 3.27B | 359.00M | 12.32% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk A/S | 258.00B |
Coloplast A/S | 26.30B |
Genmab A/S | 19.02B |
Zealand Pharma A/S | 367.97M |
Demant A/S | 22.84B |
H. Lundbeck A/S | 20.67B |
H. Lundbeck A/S | 20.67B |
Ambu A/S | 5.26B |